Official 2024 U.S. DOL Form 5500 summary for Translational Drug Development, LLC (Td2 401(k) Plan · EIN 46-4150915 · PN 001): $13.49M net assets, 167 active participants, and $61.73 per $10,000 (61.73 bps).
| Plan Sponsor | Translational Drug Development, LLC |
|---|---|
| Filing Identifier | Td2 401(k) Plan · EIN 46-4150915 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (AZ) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $13.49M |
| Active Participants | 167 |
| Direct Admin Fee Rate | $61.73 per $10,000 (61.73 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Wells Fargo Advisors Financial Advi |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($580.00, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI